Log in or Sign up for Free to view tailored content for your specialty!
Myeloproliferative Neoplasms News
Survival rates after HSCT have not improved among infants with malignant diseases
Infants with malignant diseases who underwent allogeneic hematopoietic stem cell transplantation did not demonstrate improved survival rates over a 15-year period, according to results of a study in JAMA Pediatrics.
FDA grants priority review to fedratinib for myelofibrosis
The FDA granted priority review to fedratinib for the treatment of patients with myelofibrosis.
Log in or Sign up for Free to view tailored content for your specialty!
Expanded single cord blood unit decreases hematopoietic recovery time after transplantation
An ex vivo-expanded umbilical cord blood unit appeared safe and effective as a standalone hematopoietic stem cell graft, shortening time to neutrophil and platelet recovery, according to results of a phase 2 study published in Journal of Clinical Oncology.
Two clinicians appointed to leadership roles with Atlantic Hematology Oncology
Two hematologists-oncologists have assumed key leadership roles at Atlantic Hematology Oncology, part of Atlantic Health System Cancer Care.
Filgrastim use increases risk for myelodysplastic syndrome, AML in non-Hodgkin lymphoma
Use of the granulocyte colony-stimulating factor filgrastim appeared associated with a higher risk for myelodysplastic syndrome and acute myeloid leukemia among older patients with non-Hodgkin lymphoma, according to results of a retrospective study published in Cancer.
Detection of JAK2 V617F mutations linked to myeloproliferative neoplasms
JAK2 V617F mutations detected by solid tumor sequencing appeared associated with coexistent myeloproliferative neoplasms, according to a research letter published in JAMA Oncology.
Solutions needed to lower 'unsustainable cost' of care for hematologic malignancies
Treatment costs for hematologic malignancies exceed those of other cancer types, and they place lasting burdens on patients and the health care system, according to results of a study commissioned by Leukemia & Lymphoma Society.
High-frequency basal cell carcinoma may signal increased risk for other cancers
Patients with frequent cases of basal cell carcinoma appeared to be at three times greater risk for developing other unrelated cancers, including blood, breast, colon and prostate cancers, according to study findings.
Phlebotomy and hydroxyurea improve OS, reduce thrombosis risk in polycythemia vera
Therapeutic phlebotomy and hydroxyurea improved OS and reduced risk for thrombosis among older adults with polycythemia vera at high risk for thrombotic events, according to retrospective study results.
NIH grant to fund study of fertility planning tool for cancer survivors
The NIH awarded a 5-year, $693,000 grant to The Feinstein Institute for Medical Research to develop and test a digital health platform to help young female cancer survivors evaluate their options for having children and plan for the future.
-
Headline News
CDC confirms pediatric case of bird flu in California, first in US child
November 22, 20242 min read -
Headline News
GLP-1s may curb alcohol consumption in those with obesity
November 22, 20242 min read -
Headline News
‘You can have much more control’: The rise of in-house specialty pharmacies
November 25, 202411 min read
-
Headline News
CDC confirms pediatric case of bird flu in California, first in US child
November 22, 20242 min read -
Headline News
GLP-1s may curb alcohol consumption in those with obesity
November 22, 20242 min read -
Headline News
‘You can have much more control’: The rise of in-house specialty pharmacies
November 25, 202411 min read